米国市場銘柄情報

SHTDY SINOPHARM GROUP CO

銘柄追加

12.520
-0.099-0.78%

15分遅延終値 05/02 16:00 ET

78.14億時価総額6.25直近PER

SINOPHARM GROUP COに関するコメント

ログインコメントを投稿

Moomoo AI

03/27 06:49

Analysts have downgraded their earnings per share estimates for Sinopharm Group, indicating a decline in sentiment. They also suggest that Sinopharm may underperform compared to the wider industry, but the consensus price target remains steady.

Earnings Update: Sinopharm Group Co. Ltd. (HKG:1099) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Moomoo AI

03/13 07:10

Sinopharm Group's declining ROCE trend is concerning. Increased capital investment without matching sales suggests long-term plays. High current liabilities to total assets ratio introduces risk. These trends indicate Sinopharm may not be a multi-bagger.

Sinopharm Group (HKG:1099) Will Be Hoping To Turn Its Returns On Capital Around

Spinee

01/17 16:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index(800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN-B(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亜生物科技(01873.HK)$ ...

Moomoo AI

01/16 06:51

Sinopharm Group's low P/E ratio is due to investors' limited growth expectations, leading to a reduced stock price. The poor earnings outlook from analysts also contributes to its low P/E. These conditions may continue to hinder the share price.

Investors Don't See Light At End Of Sinopharm Group Co. Ltd.'s (HKG:1099) Tunnel

Moomoo AI

2023/12/31 08:32

Sinopharm Group is currently undervalued and it might be a good time to accumulate more holdings in the stock. The positive outlook on the horizon of the company's future seems not to be fully factored into the current share price.

Why Sinopharm Group Co. Ltd. (HKG:1099) Could Be Worth Watching

Moomoo AI

2023/11/01 07:29

The declining trend in Sinopharm Group's ROCE and the stock's 42% fall in the last five years doesn't inspire investor confidence. The article doesn't consider Sinopharm Group as a potential multi-bagger based on the present analysis.

Sinopharm Group (HKG:1099) May Have Issues Allocating Its Capital

TRIUMPHANT RETURNS

2022/12/27 17:05

$ハレオン(HLN.US)$ the panadol King could reach 9 soon.
$AMCエンターテインメントクラスA(AMC.US)$$国薬(01099.HK)$$Kweichow Moutai(600519.SH)$$アリババ・グループ・ホールディング(BABA.US)$$テンセント(00700.HK)$$JD.COM(京東商城)(JD.US)$$Sheng Siong(OV8.SG)$$UOB(U11.SG)$$Singtel(Z74.SG)$$バイオエヌテック(BNTX.US)$$シー(SE.US)$

bullrider_21

2022/12/14 15:49

$国薬(01099.HK)$
Sinopharm is principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is en...